Trials / Completed
CompletedNCT01309295
An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Patients With Chronic Kidney Disease in Pre-Dialysis or Dialysis
A Prospective Study Evaluating the Efficacy and Safety of Mircera in Patients With CKD in Predialysis and Dialysis.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (actual)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This prospective observational study will assess the efficacy and safety of Mircera (methoxy polyethylene glycol-epoetin beta) in clinical practice in patients with chronic kidney disease, in pre-dialysis or on dialysis, initiated on Mircera treatment. Data from each patient will be collected over 12 months of treatment.
Conditions
Timeline
- Start date
- 2010-11-01
- Primary completion
- 2012-11-01
- Completion
- 2012-11-01
- First posted
- 2011-03-07
- Last updated
- 2016-11-02
Locations
1 site across 1 country: Albania
Source: ClinicalTrials.gov record NCT01309295. Inclusion in this directory is not an endorsement.